ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
SMC OKs four new therapies for NHS use in Scotland
pharmatimes
January 19, 2017Cost regulators in Scotland have approved NHS funding for four new medicines, expanding treatment options for lung cancer, iron excess, hepatitis C and chronic pain, but Janssen's Darzalex was rejected for multiple myeloma.
Pharma Sources Insight July 2025
